Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Keryx Biopharm Inc (KERX)

5 0.09 (1.83%)

02-21 16:00

Open:

4.9

Pre. Close:

4.91

High:

5.07

Low:

4.9

Volume:

1,261,340

Market Cap:

596M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

5.073 - 5.088

5.088 - 5.105

Low:

4.855 - 4.873

4.873 - 4.893

Close:

4.968 - 4.995

4.995 - 5.026

Technical analysis  (as of: 2018-02-21 4:25:20 PM)

Overall:

      

Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.

Target:

Six months: 5.99     One year: 7.00

Support:

Support1: 4.44    Support2: 4.01

Resistance:

Resistance1: 5.13    Resistance2: 5.99

Pivot:

4.63

Moving Averages:

MA(5): 4.89     MA(20): 4.65

MA(100): 5.26     MA(250): 6.00

MACD:

MACD(12,26): 0.04     Signal(12,26,9): -0.02

%K %D:

%K(14,3): 93.63     %D(3): 93.29

RSI:

RSI(14): 60.20

52-Week:

High: 8.38  Low: 4.01  Change(%): 2.5

Average Vol(K):

3-Month: 152086  10-Days 173051

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
KERX has closed below upper band by 8.2%. Bollinger Bands are 11.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 07 Feb 2018 17:26:15 GMT
Keryx Biopharmaceuticals' (KERX) CEO Gregory Madison on Q4 2017 Results ...

Wed, 21 Feb 2018 23:37:30 GMT
Keryx Biopharmaceuticals Inc (KERX) Files 10-K for the Fiscal Year Ended on ...

Wed, 07 Feb 2018 11:37:30 GMT
Earnings Reaction History: Keryx Biopharmaceuticals Inc, 22.2% Follow-Through ...

Tue, 20 Feb 2018 20:26:15 GMT
Option Market Alert: Keryx Biopharmaceuticals Inc Implied Price Swing Hits An ...

Wed, 21 Feb 2018 15:45:00 GMT
Do SMAs Signal a Trend Reversal? – Keryx Biopharmaceuticals Inc (NASDAQ: KERX)

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

119.22

Shares Float (M)

112.00

% Held by Insiders

% Held by Institutions

68.10

Shares Short (K)

22239

Shares Short Prior Month (K)

16710

Stock Financials

EPS

-0.880

EPS Est. Current Year

-1.230

EPS Est. Next Year

-0.320

EPS Est. Next Quarter

-0.160

Forward EPS

-0.180

Book Value (p.s.)

65.050

PEG Ratio

-0.07

Profit Margin

Operating Margin

-167.69

Return on Assets (ttm)

-107.0

Return on Equity (ttm)

1454.0

Qtrly Rev. Growth

96.0

Gross Profit (p.s.)

0.299

Sales Per Share

EBITDA (p.s.)

-0.847

Qtrly Earnings Growth

Operating Cash Flow (M)

Levered Free Cash Flow (M)

atoplab.com

Valuation

P/E

-5.68

P/E Growth Ratio

0.02

P/BV

0.08

P/S

1124716928.00

P/CF

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.